Evidence map›Paper›PMID 37765113›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Mitigation of Hepatic Impairment with Polysaccharides from Red Alga

Hajer Ben Saad, Donyez Frikha, Amir Bouallegue, Riadh Badraoui, Manel Mellouli, Hatem Kallel, Jean Marc Pujo, Ibtissem Ben Amara

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Neuroprotective properties ofIBRO neuroscience reports · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Hajer Ben SaadLaboratory of Medicinal and Environment Chemistry, Higher Institute of Biotechnology, University of Sfax, Sfax 3000, Tunisia.
Donyez FrikhaLaboratory of Marine Biodiversity and Environment, University of Sfax, Sfax 3000, Tunisia.
Amir BouallegueLaboratory for the Improvement of Plants and Valorization of Agroressources, National School of Engineering of Sfax, Sfax 3038, Tunisia.
Riadh BadraouiLaboratory of General Biology, University of Ha'il, Ha'il 45851, Saudi Arabia.
Manel MellouliAnatomopathology Laboratory, University of Sfax, Habib Bourguiba Hospital, Sfax 3029, Tunisia.
Hatem KallelIntensive Care Unit, Cayenne General Hospital, Cayenne 97300, French Guiana.ORCID 0000-0002-5663-0349
Jean Marc PujoEmergency Department, Cayenne General Hospital, Cayenne 97300, French Guiana.
Ibtissem Ben AmaraLaboratory of Medicinal and Environment Chemistry, Higher Institute of Biotechnology, University of Sfax, Sfax 3000, Tunisia.ORCID 0000-0003-3027-2747
University of Sfax · TNUniversity of French Guiana · GFTunis University · TN

Funding

Hatem kallel +594694929175
6 · The paper itself

Abstract

Sulfated polysaccharides from seaweed are highly active natural substances with valuable applications. In the present paper, attempts have been made to discuss the physicochemical and structural features of polysaccharides isolated from red marine alga

Indexed as

Alsidium corallinumbiological activitiescomputational analysisdyslipidemiahepatotoxicitypolysaccharides

Identifiers

PMID37765113
PMCPMC10537785
OpenAlexW4386780476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.